Search results
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
Motley Fool via Yahoo Finance· 12 minutes agoIn the most recent late-stage trial report, participants showed total mean weight loss of 26% over...
Boehringer’s Weight-Loss Challenger Hits Goals in Liver Study
Bloomberg· 59 minutes agoA next-generation compound from Boehringer Ingelheim GmbH and Zealand Pharma A/S hit a range of...
Revolutionary Weight Loss: Largest Ever Obesity Study Showcases Semaglutide’s Promise
SciTechDaily· 6 days agoTwo important studies stemming from the largest and most prolonged clinical trial of semaglutide’s...
Common low-calorie sweetener linked to heart attack and stroke, study finds
CNN via Yahoo News· 12 hours agoA common low-calorie sweetener called xylitol, found in gum, candy, toothpaste and more, may cause...
Grades will be given under new system at Ashland High School starting this fall
The Times-Gazette via Yahoo News· 53 minutes agoIt could add up to an additional $5,000 a year in a scholarship package − “a pretty significant...
The #1 Nut to Help You Lose Weight, Recommended by Dietitians
Eating Well via Yahoo News· 10 hours agoThe end message? One of the weight-loss benefits of walnuts may be better connecting with your...
Weight loss drugs Wegovy and Mounjaro could spawn a host of new piggyback product lines
CNBC· 5 hours agoNovo Nordisk's Wegovy weight loss drug has seen a meteoric rise in popularity. LONDON — The rapid...
Intermittent fasting plus protein pacing may boost weight loss, gut health
MedicalNewsToday via AOL· 3 days agoA study comparing continuous calorie restriction with a uniquely tailored intermittent fasting...
Study: Intermittent Fasting and High-Intensity Exercise Produce Better Weight Management Results...
Health via Yahoo News· 4 days agoA new study suggests that combining intermittent fasting with high-intensity functional training...
A weight loss drug maker's stock is rising on leaked clinical data
Quartz· 19 hours agoZealand Pharma’s stock initially jumped 7% on Thursday, after results from a phase 2 clinical trial...